Developer docs
API playgroundTry for free, no card

Search company profiles

Miiskin

Full company profile

uuid00085e8

Namestring
Miiskin
Legal namestring
Miiskin Group ApS
Websiteurl
miiskin.com
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Miiskin Group ApS is a Denmark-headquartered digital health company operating a direct-to-consumer teledermatology platform that connects patients with independent, board-certified dermatologists for asynchronous, photo-based consultations. Founded in 2022, Miiskin serves patients across all 50 US states, Mexico, and Denmark via its website and native iOS/Android applications. The core platform enables patients to self-select a dermatologist, submit high-resolution photos and clinical intake data, and receive a diagnosis, treatment plan, and prescription within 24–48 hours, compared to a reported industry-average wait of over 30 days for in-person appointments. Pricing is transparent and pay-per-visit: $55–$69 for new consultations (typically $59) and $30–$39 for prescription renewals, with no mandatory subscriptions.

The platform's technology stack includes HIPAA-compliant secure photo storage with IBM as cloud partner, GDPR and CCPA compliance, and LegitScript certification. Miiskin earns revenue through consultation fees, transaction-based compounded prescription fulfillment via Foothills Pharmacy ($48.99–$68.99 per formula), and FDA-approved generic bimatoprost fulfillment. It also operates Miiskin PRO, a provider-facing SaaS offering for dermatology practices, primary care clinics, hospitals, and cancer centers. The company has accumulated 50,000+ consultations and 1,500+ user reviews, and has secured non-dilutive grants from the Innobooster program and the Danish Innovation Fund ($200,000) to develop AI-powered skin disease triage and generative AI workflow automation. Dermatologists on the platform are independent contractors, not Miiskin employees, and patients retain freedom to fill prescriptions at any pharmacy. Stated long-term ambition is to reach 100 million people by 2040.

Short descriptiontext

Miiskin is a Denmark-headquartered teledermatology platform connecting patients with independent, board-certified dermatologists across the US, Mexico, and Denmark via asynchronous photo-based consultations, charging $59 per new visit with no subscriptions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCopenhagen, Denmark
HQ citystring
Copenhagen
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
teledermatology services, online dermatology consultations, skin condition treatment, prescription skincare, dermatology platform software
Industry4 codes
PRIMARYHLALAGAA
Dermatology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAIAK
Dermatology & Acne Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLAKACAA
General & Medical Dermatology
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
NAICS code1 code
  • Offices of Physicians62111
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Teledermatology Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Consultation Fees
TypeOne Time License
Description

Patients pay per consultation for new visits and prescription renewals. New patient consultations range from $55-$69 (typically $59), while prescription renewals cost $30-$39. This is a pay-per-visit model with no mandatory subscriptions, providing transparent upfront pricing.

miiskin.com
2Compounded Prescription Fulfillment
TypeTransaction Fee
Description

Revenue from customized prescription formulas ordered through partner pharmacy Foothills. Skincare formulas cost $48.99-$58.99, while hair-growth topical formulas cost $68.99. Patients can also use their preferred pharmacy for FDA-approved medications.

miiskin.com
3Bimatoprost/Latisse Prescription
TypeTransaction Fee
Description

FDA-approved generic bimatoprost available through partner Foothills Pharmacy for $78.99, with consultations at $59 for new visits and $39 for follow-ups specifically for Latisse prescriptions.

miiskin.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details6 tiers
1New Patient Consultation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$55-$69 per new patient consultation (typically $59 as advertised on main pages). Patients receive diagnosis, treatment plan, and prescription if medically appropriate within 24-48 hours.

miiskin.com
2Prescription Renewal Consultation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$30-$39 for returning patients requiring prescription renewals (typically $39 as advertised). Lower price point for established patients with existing conditions.

miiskin.com
3Custom Skincare Formula (Foothills)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Foothills custom formulas cost $48.99; specialized skin formulas cost $58.99. Optional add-on for patients preferring personalized compounded medications over FDA-approved options.

miiskin.com
4Hair Growth Formula (Foothills)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Topical hair-growth formulas through Foothills Pharmacy cost $68.99. Includes ingredients like Minoxidil, Finasteride, Dutasteride as prescribed.

miiskin.com
5Mexico Consultation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

499 pesos for new consultations in Mexico (reduced from 699 pesos promotional rate). Response time 1-2 business days. Follow-up questions available for 3 days included, then $299 for additional questions.

miiskin.com
6Latisse/Bimatoprost Consultation Package
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$59 for new consultations, $39 for follow-ups specifically for Latisse prescriptions. FDA-approved generic bimatoprost available through Foothills Pharmacy for $78.99. Available in all 50 states.

miiskin.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Miiskin operates a HIPAA-compliant asynchronous teledermatology platform that connects patients in the United States (all 50 states), Mexico, and Denmark with independent, board-certified dermatologists who review submitted photos, medical history, and clinical questionnaires to deliver diagnoses, personalized treatment plans, and prescriptions within 24–48 hours. Pricing is transparent and pay-per-visit (typically $59 for new consultations, $39 for prescription renewals), with optional compounded medications fulfilled through partner Foothills Pharmacy. The platform also offers Miiskin PRO, a separate provider-facing software for clinical decision support at dermatology practices, primary care clinics, hospitals, and cancer centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduced dermatology assessment wait times from over 30 days to 24-48 hours
+3 more records
Product overview1 text field

Miiskin operates a dual-sided digital health platform consisting of the Miiskin Teledermatology Platform (core product) and Miiskin PRO (provider-facing software). The platform connects patients with independent, board-certified dermatologists across all 50 U.S. states for asynchronous photo-based consultations, while the Miiskin App enables self-examination and skin tracking. A separate Mexico platform serves the Mexican market. The company also offers compounded medication services through Foothills Pharmacy and pediatric dermatology services. Miiskin received Danish Innovation Fund and Innobooster grants to develop AI-powered features including generative AI for workflow automation and skin disease triage.

Product and service5 records
1Online Dermatology Consultations
CategoryTeledermatology Consultation Service
Description

Asynchronous photo-based teledermatology service for patients in the United States, Mexico, and Denmark. Patients submit photos, medical history, and clinical questionnaires through the website or mobile app; a board-certified dermatologist reviews and delivers a diagnosis, personalized treatment plan, and (if medically appropriate) a prescription within 24–48 hours. New consultations cost $55–$69 (typically $59), prescription renewals cost $30–$39 (typically $39), with Mexican consultations priced at 499 pesos. Covers acne, anti-aging, hair loss, rosacea, eczema, hyperpigmentation, melasma, psoriasis, Latisse/bimatoprost prescriptions, and 20+ other conditions.

2Miiskin PRO
CategoryClinical Decision Support Software (B2B)
Description

Provider-facing clinical decision-support software for dermatology practices, primary care clinics, hospitals, and cancer centers. Enables healthcare organizations to offer asynchronous photo-based consultations with their existing patients, including patient image submission and information review workflows. Supports AI-powered skin disease triage and treatment recommendation workflows enhanced through Innobooster Grant funding.

3Miiskin App
CategoryMobile Health Application
Description

Native mobile application for iOS and Android enabling users to self-examine skin and moles by uploading images, track skin conditions over time (including facial photos for 36 months of inactivity retention), and share medical information with their chosen dermatologists. Available on the Apple App Store and Google Play Store.

4Miiskin Mexico Platform
CategoryRegional Teledermatology Service
Description

Separate Spanish-language teledermatology platform serving Mexican patients with dermatologists certified by the Consejo Mexicano de Dermatología. Consultations priced at 499 pesos with 1–3 business day response times. Follow-up questions included for 3 days, then 299 pesos for additional questions. Service is available throughout Mexico including CDMX and the interior republic.

5Compounded Medications via Foothills Pharmacy
CategoryCompounded Prescription Fulfillment Service
Description

Personalized compounded prescription fulfillment service delivered through partner pharmacy Foothills. Custom skincare formulas cost $48.99–$58.99; specialized topical hair-growth formulas cost $68.99 with free medication shipping. Compounded formulas may include tretinoin, hydroquinone, minoxidil, finasteride, dutasteride, azelaic acid, and other active ingredients as prescribed by Miiskin-affiliated dermatologists. Alternative to FDA-approved medications, which patients may fill at any pharmacy of their choice.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Partner pharmacy for compounded prescription formulas. Patients can select Foothills within the Miiskin platform to order personalized skincare formulas ($48.99-$68.99) with free medication shipping. Provides alternative to FDA-approved medications. Dermatologists can prescribe custom formulas including tretinoin, hydroquinone, minoxidil, and other active ingredients.

Strategic tierCoreTypeTechnology or Integration
Description

IBM serves as cloud data storage partner for patient photographs. Photos of face and skin taken for skin monitoring or telehealth consultations are stored with IBM, which complies with HIPAA and GDPR laws controlling use and storage of facial data. Miiskin has contractual agreement with IBM to verify compliance.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Ro
TypeBroad incumbent
Description

Multi-specialty telehealth platform with a dermatology/skincare offering (Ro Derm) and integrated pharmacy; competes with Miiskin on consultation-based prescription skincare at a national scale.

TypeDirect peer
Description

Direct-to-consumer online dermatology service offering personalized prescription skincare for acne, anti-aging and hyperpigmentation — directly overlaps Miiskin's core acne, anti-aging and hyperpigmentation use cases and pay-per-visit model.

TypeDirect peer
Description

Online dermatologist-led service providing personalized daily-use prescription skincare; closely matches Miiskin's photo-based intake, dermatologist review and custom-formula dispense flow.

TypeDirect peer
Description

Asynchronous online dermatology service providing photo-based dermatologist reviews for skin conditions; direct alternative to Miiskin with similar photo-first consultation workflow.

TypeDirect peer
Description

US-focused online dermatology practice offering photo-based consultations with board-certified dermatologists — near-identical service model to Miiskin's patient platform.

TypeBroad incumbent
Description

Largest US telehealth incumbent with dermatology included in its multi-specialty virtual care offering; not specialized in dermatology but competes for the same virtual-consultation demand.

TypeDirect peer
Description

Online dermatology platform connecting patients with board-certified dermatologists for customized prescription skincare; competes head-to-head with Miiskin on acne, hyperpigmentation and anti-aging compounded formulas.

TypeBroad incumbent
Description

General telehealth provider with dermatology visits included; competes with Miiskin on the virtual dermatology visit purchase decision, especially for insured patients.

TypeDirect peer
Description

UK-based online dermatology service offering customized prescription skincare formulations via subscription — comparable async photo-based model and compounding-fulfillment approach to Miiskin.

TypeBroad incumbent
Description

Large telehealth incumbent with a dedicated skin-care vertical (Hers) covering acne, anti-aging and hair loss; broader category reach and far larger marketing budget make it a dominant competitive reference point.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Miiskin

Teledermatology Servicesmiiskin.com

Miiskin is a Denmark-headquartered teledermatology platform connecting patients with independent, board-certified dermatologists across the US, Mexico, and Denmark via asynchronous photo-based consultations, charging $59 per new visit with no subscriptions.

What Miiskin does

Miiskin Group ApS is a Denmark-headquartered digital health company operating a direct-to-consumer teledermatology platform that connects patients with independent, board-certified dermatologists for asynchronous, photo-based consultations. Founded in 2022, Miiskin serves patients across all 50 US states, Mexico, and Denmark via its website and native iOS/Android applications. The core platform enables patients to self-select a dermatologist, submit high-resolution photos and clinical intake data, and receive a diagnosis, treatment plan, and prescription within 24–48 hours, compared to a reported industry-average wait of over 30 days for in-person appointments. Pricing is transparent and pay-per-visit: $55–$69 for new consultations (typically $59) and $30–$39 for prescription renewals, with no mandatory subscriptions.

The platform's technology stack includes HIPAA-compliant secure photo storage with IBM as cloud partner, GDPR and CCPA compliance, and LegitScript certification. Miiskin earns revenue through consultation fees, transaction-based compounded prescription fulfillment via Foothills Pharmacy ($48.99–$68.99 per formula), and FDA-approved generic bimatoprost fulfillment. It also operates Miiskin PRO, a provider-facing SaaS offering for dermatology practices, primary care clinics, hospitals, and cancer centers. The company has accumulated 50,000+ consultations and 1,500+ user reviews, and has secured non-dilutive grants from the Innobooster program and the Danish Innovation Fund ($200,000) to develop AI-powered skin disease triage and generative AI workflow automation. Dermatologists on the platform are independent contractors, not Miiskin employees, and patients retain freedom to fill prescriptions at any pharmacy. Stated long-term ambition is to reach 100 million people by 2040.

Miiskin firmographics

Firmographics
Name
Miiskin
Legal name
Miiskin Group ApS
Website
https://miiskin.com
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
11–50 employees
Short description
Miiskin is a Denmark-headquartered teledermatology platform connecting patients with independent, board-certified dermatologists across the US, Mexico, and Denmark via asynchronous photo-based consultations, charging $59 per new visit with no subscriptions.
Ownership category
akta.pro rank

Miiskin industry classification

Industry
Product category
Teledermatology Services
NAICS
Offices of Physicians (62111)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAGAA
Dermatology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLALAIAK
Dermatology & Acne Prescribing + Pharmacy Delivery Platforms
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLAKACAA
General & Medical Dermatology
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare

Keywords

  • Teledermatology services
  • Online dermatology consultations
  • Skin condition treatment
  • Prescription skincare
  • Dermatology platform software

Where Miiskin is headquartered

Location

Headquarters

HQ city
Copenhagen
HQ country
Denmark
HQ region
Europe

Offices3 records

Markets served

Miiskin business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Consultation Fees: Patients pay per consultation for new visits and prescription renewals. New patient consultations range from $55-$69 (typically $59), while prescription renewals cost $30-$39. This is a pay-per-visit model with no mandatory subscriptions, providing transparent upfront pricing.
  2. Compounded Prescription Fulfillment: Revenue from customized prescription formulas ordered through partner pharmacy Foothills. Skincare formulas cost $48.99-$58.99, while hair-growth topical formulas cost $68.99. Patients can also use their preferred pharmacy for FDA-approved medications.
  3. Bimatoprost/Latisse Prescription: FDA-approved generic bimatoprost available through partner Foothills Pharmacy for $78.99, with consultations at $59 for new visits and $39 for follow-ups specifically for Latisse prescriptions.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goNew Patient Consultation
One time/ perpetual licensePay-as-you-goPrescription Renewal Consultation
Unit PricingPay-as-you-goCustom Skincare Formula (Foothills)
Unit PricingPay-as-you-goHair Growth Formula (Foothills)
One time/ perpetual licensePay-as-you-goMexico Consultation
One time/ perpetual licensePay-as-you-goLatisse/Bimatoprost Consultation Package

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Miiskin product offering

Product offering

Core offering

Miiskin operates a HIPAA-compliant asynchronous teledermatology platform that connects patients in the United States (all 50 states), Mexico, and Denmark with independent, board-certified dermatologists who review submitted photos, medical history, and clinical questionnaires to deliver diagnoses, personalized treatment plans, and prescriptions within 24–48 hours. Pricing is transparent and pay-per-visit (typically $59 for new consultations, $39 for prescription renewals), with optional compounded medications fulfilled through partner Foothills Pharmacy. The platform also offers Miiskin PRO, a separate provider-facing software for clinical decision support at dermatology practices, primary care clinics, hospitals, and cancer centers.

Product overview

Miiskin operates a dual-sided digital health platform consisting of the Miiskin Teledermatology Platform (core product) and Miiskin PRO (provider-facing software). The platform connects patients with independent, board-certified dermatologists across all 50 U.S. states for asynchronous photo-based consultations, while the Miiskin App enables self-examination and skin tracking. A separate Mexico platform serves the Mexican market. The company also offers compounded medication services through Foothills Pharmacy and pediatric dermatology services. Miiskin received Danish Innovation Fund and Innobooster grants to develop AI-powered features including generative AI for workflow automation and skin disease triage.

Differentiator

Problem solved

Functional benefit

Products and services

  • Online Dermatology Consultations Asynchronous photo-based teledermatology service for patients in the United States, Mexico, and Denmark. Patients submit photos, medical history, and clinical questionnaires through the website or mobile app; a board-certified dermatologist reviews and delivers a diagnosis, personalized treatment plan, and (if medically appropriate) a prescription within 24–48 hours. New consultations cost $55–$69 (typically $59), prescription renewals cost $30–$39 (typically $39), with Mexican consultations priced at 499 pesos. Covers acne, anti-aging, hair loss, rosacea, eczema, hyperpigmentation, melasma, psoriasis, Latisse/bimatoprost prescriptions, and 20+ other conditions.
  • Miiskin PRO Provider-facing clinical decision-support software for dermatology practices, primary care clinics, hospitals, and cancer centers. Enables healthcare organizations to offer asynchronous photo-based consultations with their existing patients, including patient image submission and information review workflows. Supports AI-powered skin disease triage and treatment recommendation workflows enhanced through Innobooster Grant funding.
  • Miiskin App Native mobile application for iOS and Android enabling users to self-examine skin and moles by uploading images, track skin conditions over time (including facial photos for 36 months of inactivity retention), and share medical information with their chosen dermatologists. Available on the Apple App Store and Google Play Store.
  • Miiskin Mexico Platform Separate Spanish-language teledermatology platform serving Mexican patients with dermatologists certified by the Consejo Mexicano de Dermatología. Consultations priced at 499 pesos with 1–3 business day response times. Follow-up questions included for 3 days, then 299 pesos for additional questions. Service is available throughout Mexico including CDMX and the interior republic.
  • Compounded Medications via Foothills Pharmacy Personalized compounded prescription fulfillment service delivered through partner pharmacy Foothills. Custom skincare formulas cost $48.99–$58.99; specialized topical hair-growth formulas cost $68.99 with free medication shipping. Compounded formulas may include tretinoin, hydroquinone, minoxidil, finasteride, dutasteride, azelaic acid, and other active ingredients as prescribed by Miiskin-affiliated dermatologists. Alternative to FDA-approved medications, which patients may fill at any pharmacy of their choice.

Quantifiable outcome

  • Reduced dermatology assessment wait times from over 30 days to 24-48 hours
  • +3 more outcomes

Companies that use Miiskin

Customer profile

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Miiskin technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature6 records

Miiskin partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Foothills Professional PharmacycoreChannel Partner/ Reseller/ DistributorPartner pharmacy for compounded prescription formulas. Patients can select Foothills within the Miiskin platform to order personalized skincare formulas ($48.99-$68.99) with free medication shipping. Provides alternative to FDA-approved medications. Dermatologists can prescribe custom formulas including tretinoin, hydroquinone, minoxidil, and other active ingredients.
  • IBM (Cloud Data Storage)coreTechnology or IntegrationIBM serves as cloud data storage partner for patient photographs. Photos of face and skin taken for skin monitoring or telehealth consultations are stored with IBM, which complies with HIPAA and GDPR laws controlling use and storage of facial data. Miiskin has contractual agreement with IBM to verify compliance.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Miiskin competitors and assessment

Company assessment

Broad incumbents

  • Ro: Multi-specialty telehealth platform with a dermatology/skincare offering (Ro Derm) and integrated pharmacy; competes with Miiskin on consultation-based prescription skincare at a national scale.
  • Teladoc Health: Largest US telehealth incumbent with dermatology included in its multi-specialty virtual care offering; not specialized in dermatology but competes for the same virtual-consultation demand.
  • Doctor On Demand: General telehealth provider with dermatology visits included; competes with Miiskin on the virtual dermatology visit purchase decision, especially for insured patients.
  • Hims & Hers Health: Large telehealth incumbent with a dedicated skin-care vertical (Hers) covering acne, anti-aging and hair loss; broader category reach and far larger marketing budget make it a dominant competitive reference point.

Direct peers

  • Curology: Direct-to-consumer online dermatology service offering personalized prescription skincare for acne, anti-aging and hyperpigmentation — directly overlaps Miiskin's core acne, anti-aging and hyperpigmentation use cases and pay-per-visit model.
  • Skin + Me: Online dermatologist-led service providing personalized daily-use prescription skincare; closely matches Miiskin's photo-based intake, dermatologist review and custom-formula dispense flow.
  • First Derm: Asynchronous online dermatology service providing photo-based dermatologist reviews for skin conditions; direct alternative to Miiskin with similar photo-first consultation workflow.
  • DirectDerm: US-focused online dermatology practice offering photo-based consultations with board-certified dermatologists — near-identical service model to Miiskin's patient platform.
  • Apostrophe: Online dermatology platform connecting patients with board-certified dermatologists for customized prescription skincare; competes head-to-head with Miiskin on acne, hyperpigmentation and anti-aging compounded formulas.
  • Dermatica: UK-based online dermatology service offering customized prescription skincare formulations via subscription — comparable async photo-based model and compounding-fulfillment approach to Miiskin.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Miiskin social profiles

Digital presence

Miiskin compliance and trust

Trust signal

Compliance4 records

Miiskin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Miiskin leadership team

Management profile

Number of profiles

Profiles2 records

Miiskin funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Miiskin M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Miiskin

What does Miiskin do?

Miiskin operates a HIPAA-compliant asynchronous teledermatology platform that connects patients in the United States (all 50 states), Mexico, and Denmark with independent, board-certified dermatologists who review submitted photos, medical history, and clinical questionnaires to deliver diagnoses, personalized treatment plans, and prescriptions within 24–48 hours. Pricing is transparent and pay-per-visit (typically $59 for new consultations, $39 for prescription renewals), with optional compounded medications fulfilled through partner Foothills Pharmacy. The platform also offers Miiskin PRO, a separate provider-facing software for clinical decision support at dermatology practices, primary care clinics, hospitals, and cancer centers.

Is Miiskin a public or private company?

Miiskin is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Miiskin founded?

Miiskin was founded in 2022. It employs 11 to 50 people.

Where is Miiskin based?

Miiskin is headquartered in Copenhagen, Denmark, in the Europe region.

How does Miiskin make money?

Three revenue lines are on record. Consultation Fees are the primary driver. The others are compounded Prescription Fulfillment and bimatoprost/Latisse Prescription.

Who are Miiskin's main competitors?

Broad incumbents on record are Ro, Teladoc Health, Doctor On Demand and Hims & Hers Health. Direct peers are Curology, Skin + Me, First Derm, DirectDerm, Apostrophe and Dermatica.

Does Miiskin have an API?

Yes. Miiskin provides provider-facing software (Miiskin PRO) for healthcare practices including dermatology practices, primary care clinics, hospitals, and cancer centers to support clinical decision-making. The platform includes separate portals for patients and providers, enabling asynchronous consultations, photo-based evaluations, and treatment plan delivery. Specific API availability, endpoints, or developer documentation were not explicitly detailed in the source material.

What industry is Miiskin in?

Miiskin's product category is Teledermatology Services. Its primary akta.pro industry code is HLALAGAA, Dermatology Telemedicine Platforms, with a secondary code of HLALAIAK, Dermatology & Acne Prescribing + Pharmacy Delivery Platforms. Its NAICS code is 62111 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dermatology TimesQ&A: Jon Friis on How Generative AI Could Transform Dermatology WorkflowsMiiskin, a digital dermatology platform, has received a $200,000 grant from the Danish Innovation Fund to integrate generative AI into its platform, automating non-clinical administrative tasks such as patient intake, data organization, and provider communication to reduce clinicians' paperwork burden. The AI integration aims to streamline workflows while keeping dermatologists in control of medical decisions, with the platform already having reduced initial dermatology assessment wait times from over 30 days to 24-48 hours. Looking ahead, Miiskin aims to expand access to dermatological care to 100 million people by 2040.Cosmetics BusinessMiiskin donates £5000 to the British Skin FoundationMiiskin donated £5000 to the British Skin Foundation, the result of its Eyes On Your Skin campaign. The company donated £1 per app download in the UK, up to £5000, to raise awareness of skin cancer. Early detection is cited as the best defence against skin cancer, the most common form in the UK.Cosmetics BusinessMiiskin receives first-ever accreditation from Skin Health Alliance for dermatology appMiiskin's dermatology app received first-ever accreditation from the Skin Health Alliance after a dermatologist's review. The app tracks skin and mole changes via photos and provides reminders. Skin cancer is the most common cancer in the UK, with at least 100,000 cases diagnosed annually.MiiskinBest telehealth platforms for a Latisse prescriptionThis article is a consumer guide comparing telehealth platforms that offer Latisse (bimatoprost) prescriptions, highlighting Miiskin as the primary featured platform due to its pay-per-visit model without mandatory subscriptions, with consultations at $59 for new visits and $39 for follow-ups, and FDA-approved generic bimatoprost available through partner Foothills Pharmacy for $78.99. The article provides pricing comparisons across multiple telehealth services, noting that most competitors operate on subscription-based models with automatic refills, while Miiskin is available in all 50 states and allows patients to use their preferred pharmacy. Additional platforms are described by their general features, pricing ranges, and service models but are not individually named in the article.MiiskinMusely vs Agency vs Miiskin: What to Know Before Signing UpThe article compares three telehealth platforms—Musely, Agency, and Miiskin—that provide online dermatology consultations and prescription skincare. It highlights that while Musely and Agency operate on subscription models with assigned providers, Miiskin offers a pay-per-consultation model allowing patients to select their own dermatologists. The content details the differences in pricing structures, provider types, and pharmacy partnerships across these services.Daily Medical News‘Medicine is in crisis’: Future of dermatology relies on telehealthPrivate dermatology practices are facing a systemic crisis driven by declining Medicare reimbursements (CMS finalized its fifth consecutive year of cuts to the 2025 Medicare Physician Fee Schedule), rising administrative burdens, and physician burnout, with 46.7% of physicians in private practice in 2022 — down 13 percentage points from 2012. Telehealth platforms like Zest Health and Miiskin are emerging as alternative care models, offering asynchronous and synchronous teledermatology to improve patient access, reduce wait times (averaging 34.5 days for in-person appointments), and alleviate provider strain. Congress extended Medicare telehealth flexibilities through September 30, 2025, though industry stakeholders note this extension falls short of long-term certainty needed to sustain the sector.OresundstartupsMiiskin Gets Innobooster Grant to Advance AI-Powered Dermatology PlatformMiiskin received an Innobooster Grant to enhance its AI-powered dermatology platform for acne triage and treatment. The grant will improve dermatologist efficiency by automating routine tasks, with the platform assessing skin disease severity at 90% accuracy. The company aims to treat millions of patients globally and expand access to dermatology care.The-dermatologistCurrent Tools for Digital DermatologyDigital dermatology tools, including patient apps and physician aids, are presented as adjuncts to in-office care. Patient apps like UMSkinCheck and EczemaWise help track lesions and adherence, while AI decision aids are not yet ready for wide use. Dermatologists should still bring patients in for additional examination.The Mac ObserverMiiskin Announces Automatic Skin Imaging Feature for Melanoma DetectionMiiskin announced its app at CES, offering a free basic version and a $25/year Premium subscription. Premium includes automatic skin imaging using computer vision and augmented reality to aid full-body photos and highlight new moles. The company also provides unlimited photos and secure backup.